Product Categories
| Country: | China |
|---|---|
| Tel: | 025-58851786 |
| Mobile: | 17714337195 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol | C18H18ClN5O | 164658-13-3 | Details |
| OSTARINE(MK-2866) | C19H14F3N3O3 | 841205-47-8 | Details |
| 4-Chloro-N-(2-((5-(trifluoromethyl)pyridin-2-yl)sulfonyl)ethyl)benzamide | C15H12ClF3N2O3S | 188591-46-0 | Details |
| rel-2-(4-Chlorophenoxy)-2-methyl-N-((1S,2R)-5-(methylsulfonamido)adamantan-2-yl)propanamide | C21H29ClN2O4S | 878489-28-2 | Details |
| N-(1,3-Diphenyl-1H-pyrazol-5-yl)-4-nitrobenzamide | C22H16N4O3 | 890764-36-0 | Details |
| GNE 617 | C21H15F2N3O3S | 1362154-70-8 | Details |
| ML216 | C15H9F4N5OS | 1430213-30-1 | Details |
| INK-1117 MLN1117 | C19H17N5O3 | 1268454-23-4 | Details |
| BRD4770 | C25H23N3O3 | 1374601-40-7 | Details |
| ETC-159 | C19H17N7O3 | 1638250-96-0 | Details |
| 4-(2-Chloro-6-fluorobenzyl)-N-(furan-2-ylmethyl)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide | C21H16ClFN2O3S | 702662-50-8 | Details |
| GJ103 | C16H14N4O3S | 1459687-89-8 | Details |
| 1883510-31-3 | C19H18N4O4 | 1883510-31-3 | Details |
| Orelabrutinib | C26H25N3O3 | 1655504-04-3 | Details |
| (3-METHYLBENZO[B]THIOPHEN-2-YL)BORONIC ACID PINACOL ESTER | C15H21BO3S | 1072811-91-6 | Details |
| ASP 7663;ASP-7663;ASP7663 | C14H14FNO3 | 1190217-35-6 | Details |
| MAC-545496 | C18H18ClN5O3S | 838810-96-1 | Details |
| THPP-1 | C23H21ClN6O3 | 1257051-63-0 | Details |
| CHEMBL159279 | C16H12F6N2O | 305339-41-7 | Details |
| α,α-Diphenyl-4-[(3-pyridinylmethylene)amino]-1-piperazinepentanenitrile | C27H29N5 | 218136-59-5 | Details |
| BI605906 | C17H22F2N4O3S2 | 960293-88-3 | Details |
| NS 11394 | C23H19N3O | 951650-22-9 | Details |
| PLpro inhibitor | C22H22N2O2 | 1093070-14-4 | Details |
| BenzaMide, 5-broMo-N-[(1,2-dihydro-4,6-diMethyl-2-oxo-3-pyridinyl)Methyl]-3-[ethyl(tetrahydro-2H-pyran-4-yl)aMino]-2-Methyl- | C23H30BrN3O3 | 1403257-80-6 | Details |
| ML418 | C19H24ClN3O3 | 1928763-08-9 | Details |
| FB23 | C18H14Cl2N2O3 | 2243736-35-6 | Details |
| Insulin-like Growth Factor-1 Receptor Inhibitor | C25H26ClN5O3 | 468740-43-4 | Details |
| TCN-201 | C21H17ClFN3O4S | 852918-02-6 | Details |
| BenzaMide, N-[4-chloro-3-(trifluoroMethyl)phenyl]-2-[2-(diMethylaMino)ethoxy]-6-ethoxy- | C20H22ClF3N2O3 | 1311423-89-8 | Details |
| PEXMETINIB | C31H33FN6O3 | 945614-12-0 | Details |
| Mebeverine hydrochloride | C25H35NO5.ClH | 2753-45-9 | Details |
| MS049 (hydrochloride) | C15H25ClN2O | 2095432-59-8 | Details |
| N-(2-(Diethylamino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide | C22H27FN4O2 | 342641-94-5 | Details |
| 4-[5-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE | C16H11ClF3N3O2S | 170569-86-5 | Details |
| 3-Cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide | C23H16N4O | 781652-57-1 | Details |
| EGFR inhibitor | C21H18F3N5O | 879127-07-8 | Details |
| DB-07268 | C17H15N5O2 | 929007-72-7 | Details |
| 2002381-25-9 | C23H21N3O3 | 2002381-25-9 | Details |
| T5601640 | C19H14F3N3O3 | 924473-59-6 | Details |
| LIT-001 | C30H34F3N7O4S | 2245072-21-1 | Details |
| ATP synthase inhibitor 1 | C17H18ClN3O3S2 | 1023043-30-2 | Details |
| EZH2-A€IN-A€2 | C36H46N6O3 | 2238821-31-1 | Details |
| AGI6780 | C21H18F3N3O3S2 | 1432660-47-3 | Details |
| SR9009 | C20H24ClN3O4S | 1379686-30-2 | Details |
| 1025015-40-0 | C21H20N4O | 1025015-40-0 | Details |
| Wnt Agonist | C19H18N4O3 | 853220-52-7 | Details |
| 5-Amino-2-methyl-N-(1R-naphthalen-1-yl-ethyl)benzamide | C20H20N2O | 1093070-16-6 | Details |
| APS-2-79 | C23H22ClN3O3 | 2002381-31-7 | Details |
| N~2~-[(3,4-dimethoxyphenyl)sulfonyl]-N-(2,6-dimethylphenyl)-N~2~-(2-phenylethyl)glycinamide | C26H30N2O5S | 439940-12-2 | Details |
| ALPHA-(4-CHLOROPHENYL)-4-[(4-FLUOROPHENYL)METHYL]-1-PIPERIDINEETHANOL | C20H23ClFNO | 119431-25-3 | Details |
| CID 1375606 | C20H14Cl2N2O2 | 313493-80-0 | Details |
| PF-06446846 HYDROCHLORIDE | C22H21Cl2N7O | 1632250-50-0 | Details |
| C12-13 pareth-3 | C18H19N5O3 | 2408648-20-2 | Details |
| 1-(4-CHLORO-BENZYL)-1 H-INDOLE-3-CARBALDEHYDE | C16H12ClNO | 75629-57-1 | Details |
| 6-(5-Bromo-2-hydroxyphenyl)-2-oxo-4-phenyl-1,2-dihydropyridine-3-carbonitrile | C18H11BrN2O2 | 491871-58-0 | Details |
| KGN | C20H15NO3 | 4727-31-5 | Details |
| EI1 | C23H26N4O2 | 1418308-27-6 | Details |
| TAK-632 | C27H18F4N4O3S | 1228591-30-7 | Details |
| 825658-06-8 | C15H14Cl2N2O3S | 825658-06-8 | Details |
| RU-301 | C21H19F3N4O4S | 1110873-99-8 | Details |
| 1815580-06-3 | C21H24N4O4 | 1815580-06-3 | Details |
| BC-DXI-843 | C28H26N4O4S2 | 2421117-98-6 | Details |
| GOT1 inhibitor 2c | C19H19ClN4O | 732973-87-4 | Details |
| mebeverine alcohol | C16H27NO2 | 14367-47-6 | Details |
| SKLB 610 | C21H16F3N3O3 | 1125780-41-7 | Details |
| RAF709 | C28H29F3N4O4 | 1628838-42-5 | Details |
| SB 4 | C14H10BrNOS | 100874-08-6 | Details |
| VU6015929 | Details |
| UT-34 | C15H12F4N4O2 | 2168525-92-4 | Details |
| Pyrazinecarboxamide, 3-amino-6-chloro-5-[(3S)-4-[1-[(4-chlorophenyl)methyl]-4-piperidinyl]-3-ethyl-1-piperazinyl]- (9CI) | C23H31Cl2N7O | 906805-42-3 | Details |
| SC-1 | C21H13ClF3N3O2 | 1313019-65-6 | Details |
| AIM-100 | C23H21N3O2 | 873305-35-2 | Details |
| UNC-926 Hydochloride | C16H21BrN2O | 1184136-10-4 | Details |
| RG3039 | C21H23Cl2N5O | 1005504-62-0 | Details |
| SGC707 | C16H18N4O2 | 1687736-54-4 | Details |
| 7-DICHLORO-2-DIMETHYLAMINOMETHYL-QUINOLIN-8-OL | C12H12Cl2N2O | 747408-78-2 | Details |
| 1027847-67-1 | C26H26Cl2N2O7S | 1027847-67-1 | Details |
| 2-(4-Ethylphenoxy)-N-(4-fluoro-3-nitrophenyl)acetamide | C16H15FN2O4 | 425613-09-8 | Details |
| iGOT1-01 | C19H20N4O | 882256-55-5 | Details |
| 3-Pyridinecarboxamide, 2-amino-5-[3-(1-piperazinyl)phenyl]-N-4-pyridinyl- | C21H22N6O | 2328094-11-5 | Details |
| 1-(2,6-Dibromo-4-isopropylphenyl)-3-(pyridin-3-yl)urea | C15H15Br2N3O | 688309-70-8 | Details |
| 1111556-37-6 | C18H18N4O2 | 1111556-37-6 | Details |
| RU-302 | C24H24F3N3O2S | 1182129-77-6 | Details |
| RET V804M-IN-1 | C19H16N6O | 2414909-94-5 | Details |
| 3-(1H-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione | C25H22N6O2 | 425637-18-9 | Details |
| KY0211 | C18H17ClN2O3S | 1118807-13-8 | Details |
| CDN 1163 | C20H20N2O2 | 892711-75-0 | Details |
| 2-Fluoro-N-(3-fluoro-5-pyridin-2-yl-benzoyl)-benzenesulfonhydrazine | C18H13F2N3O3S | 2055397-28-7 | Details |
| TH 257 | C24H26N2O3S | 2244678-29-1 | Details |
| NCGC00378430 | Details |
| ML417 | C22H25N3O3 | 1386162-69-1 | Details |
| NAcM-OPT | C23H29Cl2N3O | 2089293-61-6 | Details |
| GNF-2 | C18H13F3N4O2 | 778270-11-4 | Details |
| 680C91 | C15H11FN2 | 163239-22-3 | Details |
| PZ-2891 | C20H23N5O | 2170608-82-7 | Details |
| 2095704-43-9 | C19H15ClN4O | 2095704-43-9 | Details |
| VPS34 | C21H25N7O | 1383716-46-8 | Details |
| VUN65671 | C25H30F3N3O2 | 2479465-67-1 | Details |
| Benzoic acid, 4-[[(cyclopropylmethyl)[4-(2-fluorophenoxy)benzoyl]amino]methyl]- | C25H22FNO4 | 1664335-55-0 | Details |
| 865285-29-6 | C15H9ClFN3O2 | 865285-29-6 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 | ||||